A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The proposed study will evaluate whether the use of non-pharmaceutical methods, such as surgical masks, isolation of patients and personal hygiene, are acceptable and effective in preventing the spread of influenza within the family.This will be achieved by conducting a randomized, controlled, unblinded, clinical trial. Family members of an index case with influenza like illness, will be randomly allocated to two groups. In the intervention group, family members will receive comprehensive guidance about sanitation and hygiene, as well as surgical masks to wear whenever in close contact (3 feet / 1 meter) with the index case. In addition, they will be asked to isolate the index case as much as possible. In the control group, family members will receive only standard guidance about sanitation and hygiene relevant for reducing the transmission of influenza. The primary end-point of the study will be secondary infection of influenza of at least one of the family members in order to asses the efficacy of the interventions. In addition, the compliance to those interventions will be evaluated.
The study hypothesis is that use of non-pharmaceutical methods will be acceptable and will reduce the secondary infection rate among them by 50%.
| Condition | Intervention |
|---|---|
|
Influenza |
Behavioral: sanitation and personal hygiene |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
Eligibility| Genders Eligible for Study: | Both |
Inclusion Criteria:
- Family members of an index case with influenza-like illness (ILI) during the first two days of his illness.
- No limitations will be given regarding the number of family members.
Exclusion Criteria:
- Presence of another household member with ILI during the previous two weeks.
Contacts and Locations| Contact: Manfred S Green, PhD, M.D | 972-3-7371500 ext 203 | m.green@icdc.health.gov.il |
| Principal Investigator: | Manfred S Green, PhD, M.D | ICDC |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00410176 History of Changes |
| Other Study ID Numbers: | 4335CTIL |
| Study First Received: | December 11, 2006 |
| Last Updated: | December 11, 2006 |
| Health Authority: | Israel: Ethics Commission Israel: Ministry of Health |
Additional relevant MeSH terms:
|
Influenza, Human Orthomyxoviridae Infections RNA Virus Infections |
Virus Diseases Respiratory Tract Infections Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 23, 2013